In 2023, Germany led the diuretic medicine sales market with $10.2 PPP per capita, followed by Slovakia at $3.4, Latvia at $3.3, Norway at $2.5, Finland at $2, and South Korea at $0.8. Germany and Latvia showed strong year-on-year growth with increases of 4.98% and 4.1%, respectively. Slovakia and Finland also saw moderate growth of 1.22% and 3.3%. Norway experienced a slight decline of 0.78%. South Korea demonstrated the most substantial growth rate of 9.86%, highlighting increased market penetration in the region.
Looking ahead, global diuretic medicine sales are expected to grow steadily, with emerging markets exhibiting accelerated demand driven by aging populations and increased healthcare access. Monitoring regulatory changes and advances in medical technology will be critical to understanding shifts in market dynamics.
Top countries in Diuretic Medicine Sales by Country
| # | 6 Countries | US Dollars PPP Per Capita | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 10.2 | 2023 | +3.03% | +4.98% | View data |
| 2 | 2 Slovakia | 3.4 | 2023 | +3.03% | +1.22% | View data |
| 3 | 3 Latvia | 3.3 | 2023 | 0% | +4.1% | View data |
| 4 | 4 Norway | 2.5 | 2023 | 0% | -0.78% | View data |
| 5 | 5 Finland | 2 | 2023 | 0% | +3.3% | View data |
| 6 | 6 South Korea | 0.8 | 2023 | +14.29% | +9.86% | View data |
